Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment‐resistant depression
Salloum, N. C., Fava, M., Freeman, M. P., Flynn, M., Hoeppner, B., Hock, R. S., & Mathew, S. J. | Depression and anxiety | 30 December 2018
Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter
Kuypers, K. P., de la Torre, R., Farré, M., Xicota, L., Perna, E. D. S. F., Theunissen, E. L., & Ramaekers, J. G. | Scientific reports | 18 December 2018
Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions.
Schenk, S., & Newcombe, D. | Journal of clinical psychopharmacology | 12 December 2018
3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats
Hake, H. S., Davis, J. K., Wood, R. R., Tanner, M. K., Loetz, E. C., Sanchez, A., ... & Greenwood, B. N. | Physiology & behavior | 4 December 2018
Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. | Pharmacology & therapeutics | 4 December 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., ... & Emerson, A. | Psychopharmacology | 8 September 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., ... & Emerson, A. | Psychopharmacology | 8 September 2018
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
De, D. G., Enns, J. P., Nuñez, N. A., Posa, L., & Gobbi, G. | Progress in brain research | 31 August 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel
Cipriani, A., & Cowen, P. J. | Lancet Psychiatry | 1 May 2018
Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Cameron, L. P., Benson, C. J., Dunlap, L. E., & Olson, D. E. | ACS chemical neuroscience | 24 April 2018
Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process
Inserra, A. | Frontiers in pharmacology | 5 April 2018
Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats
Horsley, R. R., Páleníček, T., Kolin, J., & Valeš, K. | Behavioural pharmacology | 13 March 2018
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Feduccia, A. A., & Mithoefer, M. C. | Progress in neuro-psychopharmacology and biological psychiatry | 7 March 2018
The re-emergence of hallucinogenic research
Begola, M. J., & Dowben, J. S. | Perspectives in psychiatric care | 20 February 2018
The re-emergence of hallucinogenic research
Begola, M. J., & Dowben, J. S. | Perspectives in psychiatric care | 20 February 2018
Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation
Curran, H. V., Nutt, D., & de Wit, H. | Psychopharmacology | 14 February 2018
Taking Psychedelics Seriously
Byock, I. | Journal of palliative medicine | 22 January 2018
Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
Thal, S. B., & Lommen, M. J. | Journal of Contemporary Psychotherapy | 6 January 2018
Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. | Frontiers in Pharmacology | 20 December 2017
Progress and promise for the MDMA drug development program
Feduccia, A. A., Holland, J., & Mithoefer, M. C. | Psychopharmacology | 20 November 2017
Dying to live: The power of transcendence in the treatment of existential anxiety
Gandy, S. | Threshold: Journal of Interdisciplinary Consciousness Studies | 2 November 2017
Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice
Curry, D. W., Young, M. B., Tran, A. N., Daoud, G. E., & Howell, L. L. | Neuropharmacology | 6 October 2017
A retrospective study of ketamine administration and the development of acute or post-traumatic stress disorder in 274 war-wounded soldiers
Mion, G., Le Masson, J., Granier, C., & Hoffmann, C. | Anaesthesia | 3 October 2017
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. | Trends in Pharmacological Sciences | 22 September 2017
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
Reiche, S., Hermle, L., Gutwinski, S., Jungaberle, H., Gasser, P., & Majić, T. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 22 September 2017